A whole-animal platform to advance a clinical kinase inhibitor into new disease spaceMasahiro Sonoshita, Arvin C. Dar, Alex Scopton et al.|Nature Chemical Biology|2018Cited by 73
Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitorsBenjamin Israelow, Matthew J. Evans, Gavriel Mullokandov et al.|Nature Communications|2014Cited by 72
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC PolypharmacologyJia Xin Yu, Arvin C. Dar, Alexander Rialdi et al.|Molecular Cancer Therapeutics|2019Cited by 21
Supplementary Synthetic Methods from Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC PolypharmacologyJia Xin Yu, Arvin C. Dar, Amanda J. Craig et al.|Unknown|2023Cited by 0
Supplementary Data Figures 1-7 from Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC PolypharmacologyJia Xin Yu, Arvin C. Dar, Amanda J. Craig et al.|Unknown|2023Cited by 0